Explain this page
Arphra AIPlain-English read on Agilent Technologies, Inc.’s valuationRatios & metrics
Profitability, returns on capital, growth, and credit — all derived from the historical income statement, balance sheet, and cash flow rows in our data warehouse.
Quality composite
A+Top tier
A snapshot of the latest fiscal year’s margins, returns on capital, balance-sheet strength and efficiency, computed from the income statement, balance sheet and cash-flow rows. Source income / balance / cash_flow.
Profitability
Gross margin52.4%
Operating margin21.3%
Net margin18.8%
ROE19.3%
ROA10.2%
ROIC16.2%
Liquidity & leverage
Current ratio1.96×
Quick ratio1.52×
Debt / equity0.50×
Net debt / EBITDA0.85×
Interest coverage13×
Efficiency & per-share
Asset turnover0.55×
Inventory days113
Days sales out.78
FCF / share$4.06
Book value / share$23.74
Valuation multiples
Price- and EV-based multiples plus shareholder yields. Snapshot at each fiscal year-end from key_metrics (FMP).
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Headline | |||||||||
| Market cap | — | — | — | $37.79B | $41.42B | — | — | — | — |
| Enterprise value | — | — | — | $40.03B | $42.98B | — | — | — | — |
| Multiples | |||||||||
| P / E | — | — | — | — | — | — | — | — | — |
| P / B | — | — | — | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — |
| EV / Sales | — | — | — | 6.15 | 6.19 | — | — | — | — |
| EV / FCF | — | — | — | 29.16 | 37.31 | — | — | — | — |
| Yields | |||||||||
| Earnings yield | — | — | — | +3.41% | +3.15% | — | — | — | — |
| Free cash flow yield | — | — | — | +3.63% | +2.78% | — | — | — | — |
| Dividend yield | — | — | — | — | — | — | — | — | — |
Profitability
Margin structure across the last 5 fiscal years
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Margins | |||||||||
| Gross margin | +53.92% | +54.35% | +50.71% | +54.30% | +52.43% | +51.17% | +53.81% | +53.68% | +53.71% |
| Operating margin | +21.32% | +23.63% | +19.76% | +22.86% | +21.29% | +21.22% | +21.24% | +21.38% | +21.31% |
| EBITDA margin | +27.88% | +27.82% | +24.92% | +28.79% | +26.41% | +26.74% | +26.38% | +26.51% | +27.34% |
| EBIT margin | +22.80% | +23.19% | +20.99% | +24.84% | +22.27% | +22.78% | +22.45% | +22.61% | +22.51% |
| Pre-tax margin | +21.52% | +21.96% | +19.60% | +23.36% | +20.65% | +21.44% | +20.69% | +20.91% | +20.82% |
| Net margin | +19.15% | +18.31% | +18.15% | +19.80% | +18.75% | +19.17% | +18.77% | +18.42% | +19.37% |
| Cost structure | |||||||||
| Cost of revenue / sales | +46.08% | +45.65% | +49.29% | +45.70% | +47.57% | +47.33% | +46.94% | +48.89% | +47.24% |
| R&D intensity | +6.98% | +6.82% | +7.04% | +7.36% | +6.55% | +7.00% | +7.18% | +6.86% | +6.98% |
| SG&A intensity | +25.62% | +23.90% | +23.91% | +23.32% | +24.60% | +23.76% | +23.54% | +23.88% | +23.96% |
| Effective tax rate | +11.03% | +16.62% | +7.39% | +15.25% | +9.20% | +10.51% | +10.78% | +10.72% | +10.56% |
Returns on capital
ROE / ROA / ROC / ROIC over the relevant capital base, plus the 3-step DuPont decomposition of ROE.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Returns | |||||||||
| Return on equity (ROE) | +22.45% | +23.64% | +21.21% | +21.85% | +19.33% | +20.70% | +20.34% | +20.69% | +20.79% |
| Return on assets (ROA) | +11.30% | +11.91% | +11.52% | +10.88% | +10.24% | +10.90% | +10.63% | +10.41% | +10.97% |
| Return on capital (ROC) | +16.59% | +20.04% | +15.73% | +15.71% | +14.65% | +15.03% | +15.29% | +15.54% | +15.01% |
| Return on invested capital (ROIC) | +14.91% | +15.53% | +14.45% | +13.61% | +12.91% | +13.57% | +13.52% | +13.39% | +13.64% |
| Asset turnover | +59.03% | +65.02% | +63.49% | +54.96% | +54.59% | +56.84% | +56.65% | +56.50% | +56.64% |
| DuPont · ROE decomposition | |||||||||
| Net margin | +19.15% | +18.31% | +18.15% | +19.80% | +18.75% | +19.17% | +18.77% | +18.42% | +19.37% |
| Asset turnover (× revenue / assets) | +59.03% | +65.02% | +63.49% | +54.96% | +54.59% | +56.84% | +56.65% | +56.50% | +56.64% |
| Equity multiplier (× assets / equity) | +198.65% | +198.53% | +184.14% | +200.85% | +188.80% | +189.95% | +191.31% | +198.80% | +189.53% |
Activity & efficiency
Turnover ratios and days-outstanding — how efficiently the business converts assets and working capital into sales and cash.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||
| Asset turnover | 0.59 | 0.65 | 0.63 | 0.55 | 0.55 | 0.57 | 0.57 | 0.57 | 0.57 |
| Fixed-asset turnover | 6.69 | 6.23 | 4.80 | 3.33 | 3.43 | — | — | — | — |
| Inventory turnover | 3.51 | 3.01 | 3.27 | 3.00 | 3.22 | — | — | — | — |
| Receivables turnover | 5.39 | 4.87 | 5.29 | 4.92 | 4.67 | — | — | — | — |
| Payables turnover | 6.53 | 5.39 | 8.06 | 5.51 | 5.80 | — | — | — | — |
| Days outstanding | |||||||||
| Days sales outstanding (DSO) | 67.70 | 74.89 | 68.96 | 74.23 | 78.12 | — | — | — | — |
| Days inventory outstanding (DIO) | 104.04 | 121.20 | 111.73 | 121.58 | 113.20 | — | — | — | — |
| Days payables outstanding (DPO) | 55.90 | 67.72 | 45.30 | 66.25 | 62.95 | — | — | — | — |
| Cash conversion cycle | 115.83 | 128.36 | 135.39 | 129.57 | 128.37 | — | — | — | — |
Cash flow quality
How well reported earnings translate into operating and free cash flow, plus reinvestment intensity.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Operating CF / Net income | 1.23 | 1.05 | 1.43 | 1.36 | 1.20 | 1.33 | 1.36 | 1.39 | 1.28 |
| FCF / Net income | 1.07 | 0.81 | 1.19 | 1.07 | 0.88 | 1.06 | 1.05 | 1.09 | 1.02 |
| FCF margin | +20.51% | +14.91% | +21.57% | +21.09% | +16.58% | +20.30% | +19.77% | +20.14% | +19.66% |
| OCF margin | +23.50% | +19.16% | +25.93% | +26.90% | +22.44% | +25.58% | +25.55% | +25.62% | +24.85% |
| CapEx / Revenue | +2.99% | +4.25% | +4.36% | +5.81% | +5.86% | +5.31% | +5.24% | +5.19% | +5.19% |
| CapEx / D&A | 0.59 | 0.92 | 1.10 | 1.47 | 1.41 | — | — | — | — |
| Stock-based comp / Revenue | +1.74% | +1.83% | +1.62% | +1.98% | +1.84% | — | — | — | — |
Per-share & shareholder yield
EPS, book value, sales, cash flow and dividends per share — plus payout / retention.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| EPS · diluted | 3.94 | 4.18 | 4.19 | 4.43 | 4.57 | 6.06 | 6.59 | 7.29 | 8.09 |
| EPS · basic | 3.98 | 4.19 | 4.22 | 4.44 | 4.59 | 6.07 | 6.56 | 7.38 | 8.13 |
| Book value / share | 17.55 | 17.68 | 19.75 | 20.27 | 23.74 | 24.05 | 25.87 | 26.30 | 28.95 |
| Tangible BV / share | 1.41 | 1.77 | 4.76 | 3.01 | 6.42 | 24.05 | 25.87 | 26.30 | 28.95 |
| Sales / share | 20.58 | 22.83 | 23.08 | 22.37 | 24.46 | 25.97 | 28.03 | 29.54 | 31.08 |
| Operating CF / share | 4.84 | 4.37 | 5.99 | 6.02 | 5.49 | 6.64 | 7.16 | 7.57 | 7.73 |
| Free cash flow / share | 4.22 | 3.40 | 4.98 | 4.72 | 4.06 | 5.27 | 5.54 | 5.95 | 6.11 |
| Dividends / share | 0.77 | 0.83 | 0.90 | 0.94 | 0.99 | 1.07 | 1.14 | 1.22 | 1.27 |
| Payout ratio | +19.50% | +19.94% | +21.37% | +21.26% | +21.64% | +21.41% | +21.66% | +22.45% | +21.05% |
| Retention ratio | +80.50% | +80.06% | +78.63% | +78.74% | +78.36% | +78.59% | +78.34% | +77.55% | +78.95% |
Growth
Year-over-year change for headline P&L lines, plus through-cycle CAGR
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E | 8y CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Top-line | ||||||||||
| Revenue · YoY | — | +8.37% | -0.22% | -4.73% | +6.73% | +7.13% | +5.93% | +6.34% | +5.76% | +4.33% |
| Gross profit · YoY | — | +9.25% | -6.90% | +2.02% | +3.06% | +4.56% | +11.39% | +6.08% | +5.81% | +4.28% |
| Profit | ||||||||||
| Operating income · YoY | — | +20.12% | -16.56% | +10.22% | -0.60% | +6.78% | +6.04% | +7.05% | +5.39% | +4.32% |
| EBITDA · YoY | — | +8.12% | -10.60% | +10.04% | -2.08% | +8.46% | +4.52% | +6.86% | +9.03% | +4.07% |
| Net income · YoY | — | +3.64% | -1.12% | +3.95% | +1.09% | +9.50% | +3.73% | +4.36% | +11.20% | +4.48% |
| Operating | ||||||||||
| EBIT · YoY | — | +10.20% | -9.70% | +12.76% | -4.33% | +9.62% | +4.38% | +7.10% | +5.29% | +4.16% |
| R&D · YoY | — | +5.90% | +3.00% | -0.42% | -5.01% | +14.46% | +8.69% | +1.66% | +7.58% | +4.33% |
| Per-share | ||||||||||
| EPS · diluted · YoY | — | +6.09% | +0.24% | +5.73% | +3.16% | +32.58% | +8.82% | +10.50% | +11.01% | +9.41% |
| EPS · basic · YoY | — | +5.28% | +0.72% | +5.21% | +3.38% | +32.29% | +8.06% | +12.52% | +10.09% | +9.34% |
Credit & leverage
Balance-sheet health + interest coverage + liquidity. Coverage ratios use period-end debt and trailing interest expense.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Leverage | |||||||||
| Total debt | $2.73B | $2.77B | $2.74B | $3.57B | $3.35B | $3.62B | $3.68B | $4.08B | $4.33B |
| Net debt | $1.25B | $1.72B | $1.15B | $2.25B | $1.57B | $1.87B | $1.82B | $2.1B | $2.25B |
| Net debt / EBITDA | 0.71 | 0.90 | 0.67 | 1.20 | 0.85 | 0.94 | 0.88 | 0.94 | 0.93 |
| Debt / equity | 0.51 | 0.52 | 0.47 | 0.61 | 0.50 | 0.52 | 0.51 | 0.55 | 0.52 |
| Debt / assets | +25.49% | +26.29% | +25.41% | +30.17% | +26.35% | +27.63% | +26.41% | +27.46% | +27.65% |
| Equity / assets | +50.34% | +50.37% | +54.31% | +49.79% | +52.97% | +52.65% | +52.27% | +50.30% | +52.76% |
| Coverage | |||||||||
| EBITDA / interest expense | 21.75 | 22.68 | 17.93 | 19.52 | 16.38 | 17.86 | 17.33 | 17.78 | 17.90 |
| Operating income / interest | 16.63 | 19.26 | 14.21 | 15.50 | 13.21 | 14.17 | 13.95 | 14.34 | 13.96 |
| Interest expense | $81M | $84M | $95M | $96M | $112M | $111.46M | $120.07M | $125.04M | $135.39M |
| Liquidity | |||||||||
| Current ratio | 2.22 | 2.03 | 2.61 | 2.09 | 1.96 | — | — | — | — |
| Quick ratio | 1.61 | 1.32 | 1.80 | 1.40 | 1.40 | — | — | — | — |
| Cash ratio | 0.87 | 0.57 | 0.99 | 0.70 | 0.76 | — | — | — | — |
| Working capital | $2.09B | $1.92B | $2.58B | $2.06B | $2.25B | — | — | — | — |
| Working capital / revenue | +33.09% | +27.99% | +37.80% | +31.71% | +32.34% | — | — | — | — |
Sourced from key_metrics + financial_ratios (loaded by load_fundamentals_extended.py).
Valuation
| Metric | FY 2025 | FY 2024 |
|---|---|---|
| P / E | — | — |
| P / B | — | — |
| EV / EBITDA | — | — |
| EV / Sales | 6.19x | 6.15x |
| Earnings yield | 3.1% | 3.4% |
| FCF yield | 2.8% | 3.6% |
Returns
| Metric | FY 2025 | FY 2024 |
|---|---|---|
| Gross margin | — | — |
| Operating margin | — | — |
| Net margin | — | — |
| ROE | 19.3% | 21.9% |
| ROA | 10.2% | 10.9% |
| ROIC | 12.6% | 12.6% |
Leverage & liquidity
| Metric | FY 2025 | FY 2024 |
|---|---|---|
| Debt / equity | — | — |
| Net debt / EBITDA | 0.85 | 1.20 |
| Interest coverage | — | — |
| Current ratio | 1.96x | 2.09x |
| Quick ratio | — | — |
Methodology. ROE / ROA / ROC use period-end balance-sheet denominators (no average-of- period smoothing). ROIC = Operating Income × (1 − inferred effective tax rate) over invested capital, with the effective tax inferred from net-to-operating income when both are positive and a 25% default otherwise. Net debt / EBITDA, debt ratios, and interest-coverage ratios are calculated point-in-time at each fiscal year-end. TTM = trailing 4 quarters (income / cash flow summed, balance sheet = most-recent quarterly snapshot). Through-cycle CAGR in the Growth panel uses the geometric mean of first-to-last period growth across the window (positive values only).